x
Elara Pharmaceuticals Ltd - Logo
[contact-form-7 404 "Not Found"]

  • The Barn Holly Berry House Rough Park,
    Hamstall Ridware, Rugeley, Staffordshire, WS15 3SQ
  • 666-888-0000
  • info@elarapharma.com
Elara Pharmaceuticals Ltd - Logo
  • info@elarapharma.com
  • The Barn Holly Berry House Rough Park,
    Hamstall Ridware, Rugeley, Staffordshire, WS15 3SQ
  • Contact Us
  • Home
  • About Us
  • Our Business
  • Our Technology
  • Real World Data
  • News
    • In The News
    • Publications
  • Careers
Logo

Contact Info

  • The Barn Holly Berry House Rough Park,
    Hamstall Ridware, Rugeley, Staffordshire, WS15 3SQ
  • +44 20 8040 0302
  • info@elarapharma.com
Real World Evidence

May2017

API 2017 (Panama | May 16-20)

Two posters highlighting the use of Tersan’s Real World Evidence (RWE) platform for large scale data mining of healthcare records are to be presented at API 2017 (Asociacion Panamericana de Infectologia) – XVIII Congresso Panamericano de Infectologia, Panama, 16-20 May 2017. The studies focus on retrospective analyses of risk factors for dengue mortality in hospitalized […]

Read More
Cancer

May2017

Broadening the reach of Precision Medicine beyond DNA

Initial results of Onco KEM and the WINTHER trial were presented at TAT 2017: 15th International Congress on Targeted Anticancer Therapies, 6-8 Mar 2017, Paris, France. The study demonstrates that the innovative Onco KEM transcriptomic-based decision support system fills a gap left by traditional DNA based targeted therapy, enabling more patients to reach a larger […]

Read More
Cancer

Nov2016

Tersan to present on Combination Therapy in Melanoma with Harvard Medical School (Paris | Nov 29 – Dec 2nd)

Dr Parmentier will present a poster “Combination Therapy in Melanoma: finding biomarkers of synergistic associations using Large Scale Drug Combination Screening and integrated Omics Data Analysis” at the Institut Pasteur International Network Scientific Symposium in Paris on November 30th.   The poster showcases the results of a collaborative study between Tersan and the Massachusetts General […]

Read More
Real World Evidence

Nov2016

Tersan to showcase Real World Evidence platform at ASTMH 2016 (Atlanta, USA | Nov 13-17)

Dr David Morley, VP Computational Technology, will be co-presenting a poster at the 65th Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH 2016) in Atlanta, USA. Poster 212 “Management of dengue hospitalizations in Brazil during and outside epidemic periods: Insights from Data Mining” is a joint presentation with Sanofi Pasteur and […]

Read More
Alzheimer's

Oct2016

Anavex and Elara Pharmaceuticals Ltd Collaborate to Accelerate Timelines and Improve Efficiency of Alzheimer’s and Parkinson’s Clinical Development Programs

NEW YORK, NY – October 5, 2016 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including Alzheimer’s disease, other central nervous system (CNS) diseases, pain and various types of cancer, today announced a collaboration with Elara Pharmaceuticals Ltd […]

Read More
Cancer

Sep2016

Elara Pharmaceuticals Ltd (Paris, Boston) and ValiSeek (London) to collaborate on Phase II Non-small Cell Lung Cancer treatment

Tersan’s advanced data analytics, using its KEM® decision support platform, will help ValiSeek boost success outlook. Tersan® Pharma, a leading digital health Company focused on developing advanced personalized therapeutic decision support systems and a provider of decision support tools and services to accelerate drug development, announces today that it has won a significant contract of […]

Read More
Precision Medicine

Jul2016

Elara Pharmaceuticals Ltd joins the Healthcare Data Institute

  Tersan is pleased to announce that the company has joined the Healthcare Data Institute. The Healthcare Data Institute is the first international think tank dedicated to Big Data in the health sector. An Orange Healthcare initiative, the Healthcare Data Institute was launched in partnership with other companies representative of the Big Data health ecosystem: […]

Read More
Precision Medicine

Jul2016

Pharma Boardroom interview with Mohammad Afshar

Interview with Mohammad Afshar – CEO, Elara Pharmaceuticals Ltd, France, 12 July 2016 Mohammad Afshar, CEO of Elara Pharmaceuticals Ltd, shares his insights on the importance of decision support tools, big data’s impact on the healthcare industry, and the need to translate this data into the production of real products. He also discusses the challenges he faced […]

Read More
Fibromyalgia

Jun2016

Is the Efficacy of Milnacipran in Fibromyalgia Predictable? A Data-Mining Analysis of Baseline and Outcome Variables

Elara Pharmaceuticals Ltd and Laboratoires Pierre Fabre have recently published the results of a clinical data mining study using KEM to identify the best responder subgroups for Milnacipran in fibromyalgia. “Is the Efficacy of Milnacipran in Fibromyalgia Predictable? A Data-Mining Analysis of Baseline and Outcome Variables”, Lilia Abtroun, PhD, Pierre Bunouf, PhD, Roger M Gendreau, MD, […]

Read More
Cancer

Jun2016

WIN 2016 Symposium (Paris | June 27-28)

The WIN 2016 Symposium is the place to be to learn about the latest in cancer research by world class presenters. Come and meet the Tersan team of Dr Mohammad Afshar, Dr Guergova-Kuras, Dr Morley and Dr Vaucouleur.

Read More

Posts navigation

1 2 3 4 5 6

Categories

  • Alzheimer's
  • Autism
  • Autoimmune disease
  • Cancer
  • Fibromyalgia
  • Kidney Transplant
  • Parkinson’s
  • Precision Medicine
  • Publications
  • Real World Evidence
  • Recent Posts
  • Type A Diabetes

Tags

alzheimer's autism cancer Event Fibromyalgia Graft rejection Influenza Kidney Laboratory lung neurological Oncology Professor Jean-Yves BLAY Centre Leon berard Parkinson Parkinson’s precisionmedicine precision medicine publication realworldevidence recent post Recent Posts Research Transplant vaccine

Elara Pharmaceuticals Ltd, The AI DRUG Development Company

  • The Barn Holly Berry House Rough Park,
    Hamstall Ridware, Rugeley, Staffordshire, WS15 3SQ
  • Call Us: +44 20 8040 0302
  • info@elarapharma.com

Menu

  • About Us
  • Our business
  • Technology
  • In The News
  • Contact Us

Subscribe

Keep in touch and subscribe to our latest news

    Elara Pharmaceuticals Ltd © 2024 All Rights Reserved